NCT03245424 Ivosidenib Expanded Access Program in Relapsed/Refractory AML With an IDH1 Mutation Status APPROVED_FOR_MARKETING Phase N/A
NCT03234985 Study of Intracellular Nucleotide Pools Determination as Biomarker of the Efficacy of the Induction Treatment in Acute Myeloid Leukemia Status COMPLETED Phase N/A
NCT03233074 Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors Status TERMINATED Phase N/A
NCT03232268 HLA-mismatched Microtransplantation Without Immunosuppressive Treatment in Patients With Myeloid Hemopathies Status COMPLETED Phase PHASE1
NCT03224819 Study of Emerfetamab (AMG 673) in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML) Status TERMINATED Phase EARLY_PHASE1
NCT03222674 Multi-CAR T Cell Therapy for Acute Myeloid Leukemia Status RECRUITING Phase PHASE1/PHASE2
NCT03207334 iCare4: Genomic Signatures With Midostaurin in Acute Myeloid Leukemia (UF-HEM-004) Status WITHDRAWN Phase PHASE2
NCT03197714 Clinical Trial of OPB-111077 in Patients With Relapsed or Refractory Acute Myeloid Leukaemia Status COMPLETED Phase PHASE1
NCT03195010 Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia Status TERMINATED Phase PHASE2
NCT03194932 Study of Venetoclax in Combination With Chemotherapy in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Leukemia of Ambiguous Lineage Status COMPLETED Phase PHASE1
NCT03187691 Safety and PK of Oral Encochleated Amphotericin B (CAMB/MAT2203) for Antifungal Prophylaxis in Patients Undergoing Induction Chemotherapy for Acute Myelogenous and Lymphoblastic Leukaemia Status WITHDRAWN Phase PHASE2
NCT03187288 Study of CFI-400945 Fumarate in Patients With Relapsed or Refractory AML or MDS Status COMPLETED Phase PHASE1
NCT03181815 Cladribine in Combination With CAG in Patients With Refractory/Relapsed Acute Myeloid Leukemia Status UNKNOWN Phase PHASE2
NCT03178617 High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma Status ACTIVE_NOT_RECRUITING Phase NA
NCT03173612 The Efficiency of CAMS (Chinese Academy of Medical Sciences)-2016 Trial for Pediatric Acute Myeloid Leukemia Status UNKNOWN Phase NA
NCT03164057 A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03154827 Safety, Tolerability and Efficacy of the BL-8040 and Atezolizumab for Maintenance Treatment in Subjects With Acute Myeloid Leukemia (AML) Status TERMINATED Phase PHASE1/PHASE2
NCT03154190 Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer Status COMPLETED Phase NA